HIV/AIDS Topics Universal Testing and Treatment Could Reduce New HIV Infections by 76%
- Details
- Category: Treatment as Prevention
- Published on Monday, 18 April 2011 22:37
- Written by UCSF
New HIV infections among gay men could decrease by 59% if all HIV positive adults now in care start antiretroviral therapy, and the number could drop further with universal annual testing, according to recently published mathematical models.
Genital Viral Load Predicts Heterosexual HIV Transmission Risk
- Details
- Category: HIV Sexual Transmission
- Published on Monday, 11 April 2011 23:11
- Written by Liz Highleyman
Higher levels of HIV RNA in semen or female genital fluids are associated with a greater likelihood of HIV transmission during sex.
Vaccine Used in STEP Trial Alters HIV Genes
- Details
- Category: HIV Vaccines
- Published on Tuesday, 29 March 2011 01:35
- Written by University of Washington
The adenovirus vaccine candidate used in the STEP trial did not significantly reduce HIV infection, but did alter the genetic makeup of the virus, according to a recent report in Nature Medicine. 
HIV Envelope Discovery Could Reveal New Vaccine Targets
- Details
- Category: HIV Vaccines
- Published on Monday, 11 April 2011 23:09
- Written by UC Davis
Researchers have identified how the HIV envelope changes shape after binding to a host cell, exposing conserved proteins that might be good targets for a vaccine.
CROI 2011: Researchers Report Further Findings from iPrEx PrEP Trial
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Monday, 07 March 2011 20:49
- Written by Paul Dalton
Investigators presented further details of findings from the ground-breaking iPrEx trial this week at the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011) in Boston. With longer follow-up, pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine (Truvada) continued to have a protective effect against HIV acquisition, but signs of mild bone loss raise potential concerns about safety.
More Articles...
- CROI 2011: Safety and Acceptability of Tenofovir Gel and Tablets for Pre-exposure Prevention
- CROI 2011: Safety and Acceptability of Tenofovir Gel and Tablets for Pre-exposure Prevention
- CDC Issues Guidance for Truvada Pre-exposure Prophylaxis
- U.S. Advocates Offer Strategies for Pre-exposure Prophylaxis to Prevent HIV Infection
Web Design and Development by